PharmaCyte Biotech postpones special meeting to Aug 31; adopts bylaw amendment

PharmaCyte Biotech, Inc.

Bylaw amendment allows board to fix record date for adjourned meetings under Nevada law.
Special meeting postponed from July 7 to August 31, 2023 to accommodate a new shareholder proposal.
Location and record date for the special meeting remain unchanged.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

PharmaCyte Biotech, Inc.: Approved an amendment to the bylaws to allow the Board to fix a record date for an adjourned or postponed meeting as permitted under Nevada law (effective 2023-07-14).

Change: bylaw amendment
Effective: 2023-07-14

Exact text from the filing

On July 14, 2023, the board of directors (the “Board”) of PharmaCyte Biotech, Inc. (the “Company”) approved an amendment (the “Bylaw Amendment”) to the Company’s bylaws, as amended (the “Bylaws”), effective immediately. Pursuant to the Bylaw Amendment, the Board may fix a record date for an adjourned or postponed meeting as permitted under Nevada law.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

PharmaCyte Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-004985

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.